Blocking neuroblastoma cell growth

An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma

24-Mar-2017 - USA

neuroblastoma – a cancer that starts in nerve tissue outside of the brain – is the third most common cancer in children and accounts for about 15 percent of pediatric cancer-related deaths.

MYC proteins drive neuroblastoma tumorigenesis in part by promoting the expression of key glycolytic enzymes such as LDHA to induce aerobic glycolysis (a type of cellular metabolism).

Dai Chung , M.D., and colleagues tested the effects of FX11, a selective inhibitor of LDHA, in a series of neuroblastoma cell lines. They found that FX11 inhibited aerobic glycolysis and growth in neuroblastoma cell lines with single-copy and amplified MYC genes. FX11 caused cell cycle arrest and induction of programmed cell death in the neuroblastoma cell lines.

The findings demonstrate that LDHA is a potential target for the development of novel neuroblastoma treatments and suggest that LDHA antagonists should be further tested in preclinical neuroblastoma models.

Original publication

Other news from the department science

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?